BridgeMD
New treatment option for Acute Leukemia
Official title Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
ClinicalTrials.gov ID: NCT06907797
What this study is testing
- What it's testing
- This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older
- English speaking
- Ability to understand and willingness to sign written informed consent
- Clinical suspicion of acute leukemia
- Admitted to DFCI-affiliated inpatient unit
You likely can't join if
- Cognitive impairment rendering the individual unable to participate in beta testing
- This will be assessed by focused chart review and consultation with the patients' inpatient care team.
- The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years...
- Inability to participate in in-person application testing.
- Patients who participated in alpha-testing through protocol 23-404 (Appendix A)
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.